Zacks Small Cap Research on MSN
DWTX: 143 patients enrolled in phase 2b trial of Halneuron®; results expected in 3Q26
By David Bautz, PhD NASDAQ: DWTX READ THE FULL DWTX RESEARCH REPORT Business Update 143 Patients Enrolled in Phase 2b Trial ...
Scientists placed 200,000 living human brain cells on a microchip and taught it how to play a doomsday video game — and are now using the dystopian tech to power AI data centers. Australian biotech ...
Mike Armour does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...
Emmalee Ford works for Family Planning Australia, a non-government reproductive and sexual health organisation. Tessa Copp receives funding from a National Health and Medical Research Council (NHMRC) ...
The field of neuroplasticity is increasingly exploring the non-neuronal components that shape synaptic, cellular, and circuit-level adaptation in the brain.
A computer platform that runs on human neurons (and recently showed off said neurons’ ability to play DOOM) now wants in on the data center boom. Australia-based Cortical Labs announced today that it ...
Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Red meat is rich in iron but may not fully make up for ...
Detailed price information for Cassava Sciences Inc (SAVA-Q) from The Globe and Mail including charting and trades.
Detailed price information for Ovid Therapeutics Inc (OVID-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results